Catheter re-dose may tame pain and nausea after Weight-Loss surgery
NCT ID NCT07655908
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a temporary catheter placed during laparoscopic sleeve gastrectomy can be used to re-dose nerve-blocking medicine (bupivacaine and dexamethasone) if severe pain or nausea break through after surgery. It includes 30 high-risk patients, such as young women or those with a history of severe post-surgery symptoms. The goal is to see if this approach is safe, feasible, and effective at reducing pain and nausea without needing extra opioids.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
bupivacaine and dexamethasone
What this could lead to
If it works, this approach could offer a way to manage severe pain and nausea after gastric sleeve surgery without relying on opioids.
What could go wrong
This is a small, early-stage study with only 30 participants, so results may not apply to everyone. The catheter placement itself carries risks like infection or blockage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••